Cargando…

De novo design of type II topoisomerase inhibitors as potential antimicrobial agents targeting a novel binding region

By 2050, it is predicted that antimicrobial resistance will be responsible for 10 million global deaths annually, more deaths than cancer, costing the world economy $100 trillion. Clearly, strategies to address this problem are essential as bacterial evolution is rendering our current antibiotics in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Orritt, Kyle M., Feng, Lipeng, Newell, Juliette F., Sutton, Jack N., Grossman, Scott, Germe, Thomas, Abbott, Lauren R., Jackson, Holly L., Bury, Benjamin K. L., Maxwell, Anthony, McPhillie, Martin J., Fishwick, Colin W. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298182/ https://www.ncbi.nlm.nih.gov/pubmed/35919336 http://dx.doi.org/10.1039/d2md00049k

Ejemplares similares

Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV
por: Grossman, Scott, et al.
Publicado: (2023)

The potential use of single-particle electron microscopy as a tool for structure-based inhibitor design
por: Rawson, S., et al.
Publicado: (2017)

Recent developments in the structural characterisation of the IR and IGF1R: implications for the design of IR–IGF1R hybrid receptor modulators
por: Turvey, Samuel J., et al.
Publicado: (2022)

DNA Topoisomerase Inhibitors: Trapping a DNA-Cleaving Machine in Motion
por: Bax, Benjamin D., et al.
Publicado: (2019)

Identification of a small molecule inhibitor of Ebola virus genome replication and transcription using in silico screening
por: Easton, Victoria, et al.
Publicado: (2018)

DNA topoisomerase IIα controls replication origin cluster licensing and firing time in Xenopus egg extracts
por: Gaggioli, Vincent, et al.
Publicado: (2013)

Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
por: Rawson, Shaun, et al.
Publicado: (2018)

Topo2008: DNA Topoisomerases in Biology and Medicine
por: Maxwell, Tony, et al.
Publicado: (2009)

High-throughput assays for DNA gyrase and other topoisomerases
por: Maxwell, Anthony, et al.
Publicado: (2006)

Novel Synthetic Polyamines Have Potent Antimalarial Activities in vitro and in vivo by Decreasing Intracellular Spermidine and Spermine Concentrations
por: El Bissati, Kamal, et al.
Publicado: (2019)

Getting the word out: how to talk to the public about your research
por: Orritt, Rachel, et al.
Publicado: (2020)

Patient testimony: hyper-IgE  syndrome and associated lung  infections
por: Orritt, Rachel, et al.
Publicado: (2019)

Inhibition of Topoisomerases by Metal Thiosemicarbazone Complexes
por: Jiang, Xiaohua, et al.
Publicado: (2023)

Functional Characterization of the γ-Aminobutyric Acid Transporter from Mycobacterium smegmatis MC(2) 155 Reveals Sodium-Driven GABA Transport
por: Pavić, Ana, et al.
Publicado: (2021)

Proteasomal inhibition potentiates drugs targeting DNA topoisomerase II
por: Lee, Ka C., et al.
Publicado: (2016)

Evodiamine Stabilizes Topoisomerase I-DNA Cleavable Complex to Inhibit Topoisomerase I Activity
por: Chan, Agnes L.-F., et al.
Publicado: (2009)

Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV
por: Pitts, Steven L., et al.
Publicado: (2011)

Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements
por: Takahashi, Diane T, et al.
Publicado: (2019)

Fluorescently labeled circular DNA molecules for DNA topology and topoisomerases
por: Gu, Maxwell, et al.
Publicado: (2016)

Correction to ‘Expanding the type IIB DNA topoisomerase family: identification of new topoisomerase and topoisomerase-like proteins in mobile genetic elements’
Publicado: (2022)

Topoisomerase gets around
por: Dove, Alan W.
Publicado: (2002)

Topoisomerase VI is a chirally-selective, preferential DNA decatenase
por: McKie, Shannon J, et al.
Publicado: (2022)

Why is medical oxygen a challenge for people travelling by air?
por: Orritt, Rachel, et al.
Publicado: (2019)

The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV
por: Kokot, Maja, et al.
Publicado: (2022)

Topoisomerases facilitate transcription of long genes linked to autism
por: King, Ian F., et al.
Publicado: (2013)

CSGID Solves Structures and Identifies Phenotypes for Five Enzymes in Toxoplasma gondii
por: Lykins, Joseph D., et al.
Publicado: (2018)

Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines.
por: Houlbrook, S., et al.
Publicado: (1995)

Actions of a Novel Bacterial Topoisomerase Inhibitor against Neisseria gonorrhoeae Gyrase and Topoisomerase IV: Enhancement of Double-Stranded DNA Breaks
por: Dauda, Soziema E., et al.
Publicado: (2023)

Bacterial topoisomerase I and topoisomerase III relax supercoiled DNA via distinct pathways
por: Terekhova, Ksenia, et al.
Publicado: (2012)

Topoisomerase 3β is the major topoisomerase for mRNAs and linked to neurodevelopment and mental dysfunction
por: Ahmad, Muzammil, et al.
Publicado: (2017)

Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ
por: Fief, Cole A., et al.
Publicado: (2019)

Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase II α gene transfer is independent of topoisomerase II β
por: Zhou, Z, et al.
Publicado: (2001)

Alchemix, p53 and topoisomerase
por: Grand, Roger J, et al.
Publicado: (2015)

Mechanism of Type IA Topoisomerases
por: Dasgupta, Tumpa, et al.
Publicado: (2020)

DNA-Topology Simplification by Topoisomerases
por: Hanke, Andreas, et al.
Publicado: (2021)

Essential Components of Synthetic Infectious Prion Formation De Novo
por: Jack, Kezia, et al.
Publicado: (2022)

Topoisomerase IV can functionally replace all type 1A topoisomerases in Bacillus subtilis
por: Reuß, Daniel R, et al.
Publicado: (2019)

Recent developments in topoisomerase-targeted cancer chemotherapy
por: Hevener, KirkE., et al.
Publicado: (2018)

The ancestral role of ATP hydrolysis in type II topoisomerases: prevention of DNA double-strand breaks
por: Bates, Andrew D., et al.
Publicado: (2011)

Modeling Allosteric Mechanisms of Eukaryotic Type II Topoisomerases
por: Evoli, Stefania, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hpko92j1tah7t69r3dl15l92ch